SBIR/STTR Research Award
OPIOID TREATMENT SUPPORT SYSTEM
Award amount
$99,916Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PERSONAL IMPROVEMENT COMPUTER SYSTEMS
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2010-1
- Topic code
- NIDA
Research abstract
The purpose of this Phase I project is to design, develop and evaluate the prototype OTSS system. In the first months of our project, we will create the content for the patient assessment and monitoring tools. At the same time, we will be working on the adaptation of the technical platform and development of the web interface. OTSS will be developed using our proprietary CERTAS platform. Following system development and testing, we will conduct a small trial with patients on buprenorphine therapy and their providers (3 providers and 9 patients) to obtain feedback on their use of the system. Lastly we will develop a list of modifications for the proposed Phase II version of the system based on the feedback obtained from our trial.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)